RE:Knights Loans EbbFlow88 wrote: I can't remember but I think the number of loans has decreased. Seems like they have been letting them run off and not renewing.
The Synergy loan is maturing in 2022 and 60 degree pharma and M8 in 2023. That would be about $24M in proceeds to redirect to M&A.
They already said they will not be investing in any new funds but does anyone have any ideas about loans?
I think they would still entertain loans but Samira is interested in real collateral (e.g. Samira wasn't interested in the Appili deal for that reason but Loadzone Holdings was).
As a one-stop-shop for young and upcoming drug developers, I think there is always room for negotiation and to offer cash as a loan or cash for ownership rights. Many factors at play in the final deal decisions